IPCRG is delighted to confirm Boehringer Ingelheim, Mundipharma, AstraZeneca, Teva, Novartis and Xepa Soul Pattinson as sponsors for our 4th Scientific Meeting in Singapore, the first in Asia.
We will have over 80 primary care research abstracts being presented during the day and half meeting with several teams also competing for a prize at our first Research school on Saturday 30th May.
On Saturday morning, delegates from our Scientific Meeting and Research School will join together for a presentation by Professor Onno van Schayck – “The 3 billion people question: What are the causes of COPD in low and middle income countries, and how can we prevent them?”
Registrations are continuing to come in and remain open up until the 22nd May.
Details of the abstracts being presented will be available online w/c 4th May on www.ipcrg2015.org Those accepted for publication by the IPCRG’s peer-reviewed open access open source journal published by Nature, npj-PCRM will be available on http://www.nature.com/npjpcrm/ on 21st May.
Follow us on Twitter @IPCRG2015
We look forward to an interesting and exciting meeting and research school.
2015 Scientific Programme Committee & Research School Faculty
Dr Tan Tze Lee, Singapore, Chair
Dr Tan Ngiap Chuan, Singapore
Professor David Price, Singapore
Professor Josefina S Isidro-Lapena, Philippines
Dr Vinh Nhu Nguyen, Vietnam
Professor Chunxue Bai, China
Professor Khoo Ee Ming, Malaysia
Professor Aziz Sheikh
The International Primary Care Respiratory Group (IPCRG) is a charity registered in Scotland working internationally (SC No: 035056) and a company limited by guarantee (Company number 256268)
The IPCRG is the Respiratory Special Interest Group of WONCA Europe and an Organisation in Collaborative Relations with WONCA Global The IPCRG is the primary care representative on WHO-Global Alliance against Chronic Respiratory Diseases (GARD) Planning Executive Supporter of the NCD Alliance www.theipcrg.org